Published in PLoS Pathog on April 29, 2010
Occludin: one protein, many forms. Mol Cell Biol (2011) 1.53
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS (2012) 1.44
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17
Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS (2013) 1.15
Olfactory nerve--a novel invasion route of Neisseria meningitidis to reach the meninges. PLoS One (2010) 1.10
Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03
Matrix metalloproteinases as therapeutic targets for stroke. Brain Res (2015) 0.97
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Modulation of cell-cell junctional complexes by matrix metalloproteinases. J Dent Res (2012) 0.95
Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med (2013) 0.90
Mechanism of meningeal invasion by Neisseria meningitidis. Virulence (2012) 0.89
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases. Mediators Inflamm (2015) 0.89
Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest (2015) 0.87
Cell invasion by Neisseria meningitidis requires a functional interplay between the focal adhesion kinase, Src and cortactin. PLoS One (2012) 0.87
Defense at the border: the blood-brain barrier versus bacterial foreigners. Future Microbiol (2012) 0.86
Intracellular Cleavage of the Cx43 C-Terminal Domain by Matrix-Metalloproteases: A Novel Contributor to Inflammation? Mediators Inflamm (2015) 0.85
Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression. J Neurochem (2013) 0.85
Concepts and mechanisms: crossing host barriers. Cold Spring Harb Perspect Med (2013) 0.83
Host-pathogen interactions in bacterial meningitis. Acta Neuropathol (2016) 0.82
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget (2015) 0.82
Role of epidermal growth factor receptor signaling in the interaction of Neisseria meningitidis with endothelial cells. Infect Immun (2013) 0.82
Deciphering the contribution of human meningothelial cells to the inflammatory and antimicrobial response at the meninges. Infect Immun (2013) 0.81
Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier. PLoS One (2013) 0.80
Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. PLoS One (2013) 0.80
Phenotypic pattern-based assay for dynamically monitoring host cellular responses to Salmonella infections. PLoS One (2011) 0.79
Recombinant Treponema pallidum protein Tp0965 activates endothelial cells and increases the permeability of endothelial cell monolayer. PLoS One (2014) 0.79
Matrix metalloproteinase-8 expression in periodontal tissues surgically removed from diabetic and non-diabetic patients with periodontal disease. J Clin Periodontol (2011) 0.78
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab (2016) 0.77
Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier. Oncotarget (2016) 0.76
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Oncotarget (2016) 0.76
Differential transcription profiles of long non-coding RNAs in primary human brain microvascular endothelial cells in response to meningitic Escherichia coli. Sci Rep (2016) 0.76
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis. BMC Infect Dis (2014) 0.76
Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxid Med Cell Longev (2016) 0.75
A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat Rev Microbiol (2017) 0.75
Neisseria gonorrhoeae Challenge Increases Matrix Metalloproteinase-8 Expression in Fallopian Tube Explants. Front Cell Infect Microbiol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
Dexamethasone in adults with bacterial meningitis. N Engl J Med (2002) 11.10
Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med (2004) 7.87
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet (2007) 5.11
Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol (2001) 4.99
A 220-kD undercoat-constitutive protein: its specific localization at cadherin-based cell-cell adhesion sites. J Cell Biol (1991) 3.31
Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol (1997) 3.22
Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest (1998) 3.17
Treatment of bacterial meningitis. N Engl J Med (1997) 3.07
Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science (2009) 2.96
Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci (2005) 2.61
Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet (1991) 2.54
Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett (2003) 2.46
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol (2000) 2.42
Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol (2005) 2.08
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol (2008) 2.04
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest (2005) 1.92
Tight junctions. J Cell Sci (1998) 1.86
Tight junctions of the blood-brain barrier. Cell Mol Neurobiol (2000) 1.81
Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol (2006) 1.78
Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med (1999) 1.71
Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J (1999) 1.71
Mechanisms of neisserial serum resistance. Mol Microbiol (1999) 1.71
Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect Immun (1998) 1.68
Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis (2006) 1.68
Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis (2002) 1.64
Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest (1986) 1.63
Interaction of Neisseria meningitidis with a polarized monolayer of epithelial cells. Infect Immun (1997) 1.61
Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev (2001) 1.59
Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology (1993) 1.54
The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci (2004) 1.49
Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med (1998) 1.46
Targeting of the pro-apoptotic VDAC-like porin (PorB) of Neisseria gonorrhoeae to mitochondria of infected cells. EMBO J (2000) 1.43
Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem (1998) 1.43
Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci (1999) 1.35
Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol (2002) 1.33
Traversal of a polarized epithelium by pathogenic Neisseriae: facilitation by type IV pili and maintenance of epithelial barrier function. Mol Med (1996) 1.31
Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect (2000) 1.27
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23
Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis (1999) 1.20
Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun (1996) 1.19
Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro (2006) 1.08
Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology (2006) 1.08
Assessment of cytotoxicity by emerging impedance spectroscopy. Toxicol Appl Pharmacol (2005) 1.06
Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res (2004) 1.06
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol (1998) 1.05
Bim and Bmf synergize to induce apoptosis in Neisseria gonorrhoeae infection. PLoS Pathog (2009) 0.99
Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect Immun (2006) 0.96
Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis. PLoS Pathog (2009) 0.96
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol Rep (2006) 0.92
The matrix metalloproteinases and CNS plasticity: an overview. J Neuroimmunol (2007) 0.92
Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol (2006) 0.88
Classification of signals for blocking apoptosis in vascular endothelial cells. J Biochem (1994) 0.86
Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol (1997) 0.86
Levels of nitric oxide correlate with high levels of tumor necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis. Clin Infect Dis (1996) 0.82
Pathogenesis and pathophysiology of bacterial meningitis. Annu Rev Med (1993) 0.80
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
RIDOM: Ribosomal Differentiation of Medical Micro-organisms Database. Nucleic Acids Res (2002) 2.33
RIDOM: comprehensive and public sequence database for identification of Mycobacterium species. BMC Infect Dis (2003) 2.33
Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology (2002) 2.17
Genetic analysis of meningococci carried by children and young adults. J Infect Dis (2005) 2.12
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 2.06
Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg Infect Dis (2006) 1.78
A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev (2006) 1.62
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros (2007) 1.37
Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol (2002) 1.33
Subcutaneous Taenia crassiceps infection in a patient with non-Hodgkin's lymphoma. Am J Trop Med Hyg (2006) 1.27
Transcriptome analysis of Neisseria meningitidis during infection. J Bacteriol (2003) 1.22
Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI. J Clin Microbiol (2003) 1.22
Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol (2004) 1.19
Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program. J Clin Microbiol (2006) 1.17
Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages. Am J Trop Med Hyg (2009) 1.16
A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells. J Bacteriol (2007) 1.16
Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. FEBS J (2006) 1.14
Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Cell Microbiol (2007) 1.13
Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome. PLoS One (2011) 1.12
EpiScanGIS: an online geographic surveillance system for meningococcal disease. Int J Health Geogr (2008) 1.11
Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bacteriol (2007) 1.10
A point mutation in the sensor histidine kinase SaeS of Staphylococcus aureus strain Newman alters the response to biocide exposure. J Bacteriol (2009) 1.10
Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl). J Clin Microbiol (2004) 1.10
Initial patient cluster and first positive biopsy findings in an outbreak of acute muscular Sarcocystis-like infection in travelers returning from Tioman island, Peninsular Malaysia, in 2011. J Clin Microbiol (2012) 1.09
Characterisation of EmMPK1, an ERK-like MAP kinase from Echinococcus multilocularis which is activated in response to human epidermal growth factor. Int J Parasitol (2006) 1.09
Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence. J Bacteriol (2010) 1.08
Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell Microbiol (2004) 1.08
Transmission of Armillifer armillatus ova at snake farm, The Gambia, West Africa. Emerg Infect Dis (2011) 1.08
Genome flexibility in Neisseria meningitidis. Vaccine (2009) 1.06
Echinococcus multilocularis infection of several Old World monkey species in a breeding enclosure. Am J Trop Med Hyg (2007) 1.06
Analysis of the heat shock response of Neisseria meningitidis with cDNA- and oligonucleotide-based DNA microarrays. J Bacteriol (2002) 1.04
Immunochromatographic test with recombinant Em18 antigen for the follow-up study of alveolar echinococcosis. Clin Vaccine Immunol (2011) 1.03
Emergence of polycystic neotropical echinococcosis. Emerg Infect Dis (2008) 1.03
Rudolf Virchow and the recognition of alveolar echinococcosis, 1850s. Emerg Infect Dis (2007) 1.00
Microbiological evaluation of the new VITEK 2 Neisseria-Haemophilus identification card. J Clin Microbiol (2007) 1.00
Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab (2009) 1.00
Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clin Vaccine Immunol (2010) 0.98
Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers. Int J Med Microbiol (2006) 0.97
Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila. Infect Immun (2003) 0.97
Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect Immun (2006) 0.96
Intracellular survival and replication of Neisseria meningitidis in human brain microvascular endothelial cells. Int J Med Microbiol (2006) 0.96
Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect Immun (2002) 0.96
Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerg Infect Dis (2010) 0.94
Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses (2006) 0.94
Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. J Clin Microbiol (2007) 0.93
Assessing the risk potential of porcine circoviruses for xenotransplantation: consensus primer-PCR-based search for a human circovirus. Xenotransplantation (2004) 0.93
Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology (2011) 0.93
The role of human dendritic cells in meningococcal and listerial meningitis. Int J Med Microbiol (2003) 0.93
Whole-genome sequence of the transformable Neisseria meningitidis serogroup A strain WUE2594. J Bacteriol (2011) 0.93
Transcriptome-based antigen identification for Neisseria meningitidis. Vaccine (2003) 0.92
Linguatuliasis in Germany. Emerg Infect Dis (2006) 0.92
Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci. J Clin Microbiol (2006) 0.92
Nuclear localization signal of murine CMP-Neu5Ac synthetase includes residues required for both nuclear targeting and enzymatic activity. J Biol Chem (2002) 0.89
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups. Pediatr Infect Dis J (2013) 0.89
Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells. Cell Microbiol (2005) 0.89
Expression of the meningococcal adhesin NadA is controlled by a transcriptional regulator of the MarR family. Mol Microbiol (2009) 0.88
Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients. J Clin Microbiol (2010) 0.88
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrob Agents Chemother (2010) 0.88
Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine. J Infect (2012) 0.87
Cell invasion by Neisseria meningitidis requires a functional interplay between the focal adhesion kinase, Src and cortactin. PLoS One (2012) 0.87
Alveolar echinococcosis-spreading disease challenging clinicians: a case report and literature review. World J Gastroenterol (2013) 0.86
Analysis of differential gene expression in Echinococcus multilocularis larval stages by means of spliced leader differential display. Int J Parasitol (2003) 0.86
Isolation of Salmonella enterica serotype newport from a partly ruptured splenic abscess in a traveler returning from Zanzibar. J Clin Microbiol (2007) 0.86
Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development. BMC Biol (2014) 0.86
Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis. J Clin Microbiol (2009) 0.86
Evaluation of new colorimetric vitek 2 yeast identification card by use of different source media. J Clin Microbiol (2008) 0.86
Living in a changing environment: insights into host adaptation in Neisseria meningitidis from comparative genomics. Int J Med Microbiol (2007) 0.85
Translation control is critical during acute and chronic stages of toxoplasmosis infection. Expert Rev Anti Infect Ther (2011) 0.85
Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008. Scand J Infect Dis (2010) 0.84
Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae. Med Microbiol Immunol (2010) 0.84
Export of cyst wall material and Golgi organelle neogenesis in Giardia lamblia depend on endoplasmic reticulum exit sites. Cell Microbiol (2012) 0.84
The molecular mechanisms of larval cestode development: first steps into an unknown world. Parasitol Int (2005) 0.84
A hundred years of controversy about the taxonomic status of Echinococcus species. Acta Trop (2010) 0.84
Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Pediatr Transplant (2011) 0.83
Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg (2010) 0.83
Evaluation of a commercial Echinococcus Western Blot assay for serological follow-up of patients with alveolar echinococcosis. Clin Vaccine Immunol (2008) 0.83
Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases. Infect Immun (2010) 0.83
The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure. Appl Environ Microbiol (2010) 0.82
Microarray analyses of meningococcal genome composition and gene regulation: a review of the recent literature. FEMS Microbiol Rev (2006) 0.82
Characterization of FarR as a highly specialized, growth phase-dependent transcriptional regulator in Neisseria meningitidis. Int J Med Microbiol (2011) 0.82
Polymorphism of Candida albicans is a major factor in the interaction with human dendritic cells. Int J Med Microbiol (2005) 0.82
Role of epidermal growth factor receptor signaling in the interaction of Neisseria meningitidis with endothelial cells. Infect Immun (2013) 0.82
Epitope mapping of the O-chain polysaccharide of Legionella pneumophila serogroup 1 lipopolysaccharide by saturation-transfer-difference NMR spectroscopy. Eur J Biochem (2002) 0.81
Capillary activity of surgical sutures and suture-dependent bacterial transport: a qualitative study. Surg Infect (Larchmt) (2005) 0.81
The European networking for combating meningococcal disease. FEMS Microbiol Rev (2007) 0.81
Can we, should we, eradicate the meningococcus? Vaccine (2012) 0.81
Evaluation of one- and two-color gene expression arrays for microbial comparative genome hybridization analyses in routine applications. J Clin Microbiol (2010) 0.81
Mammalian cell transcriptome in response to meningitis-causing pathogens. Expert Rev Mol Diagn (2009) 0.80
Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment. Scand J Infect Dis (2010) 0.79
Sequence analysis of serotype-specific synthesis regions II of Haemophilus influenzae serotypes c and d: evidence for common ancestry of capsule synthesis in Pasteurellaceae and Neisseria meningitidis. Res Microbiol (2011) 0.79
Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease. J Clin Microbiol (2006) 0.79